Claims for Patent: 10,064,906

Summary for Patent: 10,064,906

Title:	Method of preparing fermented crude extract having angiotensin converting enzyme inhibiting activity
Abstract:	This invention is related to a method of preparing a fermented crude extract having angiotensin converting enzyme inhibiting activity. The method comprises the following steps. A material is dried, milled, and then mixed with water in a weight ratio of 1:11 to form a mixture solution. 0.1 vol % .alpha.-amylase is used to perform hydrolysis at 95.degree. C. for 1 hour. 0.1 vol % glucoamylase is used to perform hydrolysis at 65.degree. C. for 4 hours. A lactic acid bacterium is added in a culture medium containing the mixture solution to perform fermentation for 24 hours. The culture medium is centrifuged to take the supernatant thereof, and the supernatant is boiled for 20 minutes. The supernatant is filtered to obtain a fermented crude extract having angiotensin converting enzyme inhibiting activity.
Inventor(s):	Wang; Shu-Chen (Tainan, TW), Duh; Pin-Der (Tainan, TW), Chen; Shih-Ying (Tainan, TW), Chang; Chen-Kai (Tainan, TW), Chen; Jung-Tsai (Tainan, TW), Chiu; Chih-Kuang (Tainan, TW)
Assignee:	Chia Nan University of Pharmacy & Science (Tainan, TW)
Application Number:	14/985,810
Patent Claims:	1. A method of preparing a fermented crude extract having angiotensin converting enzyme inhibiting activity, comprising: (step 1) drying and milling a material, and then mixing the material with water in a weight ratio of 1:11 to form a mixture solution, wherein the material is selected from a group consisting of sunflower seeds, red quinoa, peanut residue, linseed residue, carrot, and sesame residue; (step 2) adding 0.1 vol % .alpha.-amylase in the mixture solution to perform hydrolysis at 95.degree. C. for 1 hour; (step 3) adding 0.1 vol % glucoamylase in the mixture solution to perform hydrolysis at 65.degree. C. for 4 hours; (step 4) adding 1% (w/w) of a lactic acid bacterium in a culture medium containing the mixture solution to perform fermentation for 24 hours, wherein the lactic acid bacterium is Lactobacillus casei or Lactobacillus plantarum; (step 5) centrifuging the culture medium to take a supernatant thereof and boiling the supernatant for 20 minutes; (step 6) filtering the supernatant and collecting the supernatant liquid passed through a filter to remove unwanted elements to obtain the fermented crude extract; and (step 7) measuring the angiotensin converting enzyme inhibiting activity of the fermented crude extract. 2. The method of claim 1, wherein the material is selected from carrot, sesame residue, linseed residue, and red quinoa. 3. The method of claim 1, wherein a pH value of the mixture solution in the step 3 has been adjusted to pH 4.5. 4. The method of claim 1, wherein the lactic acid bacterium in the step 4 has been cultured for 24 hours. 5. The method of claim 1, wherein the fermentation in step 4 is performed at 35-37.degree. C. and rotated at 70-80 rpm for 24 hours. 6. The method of claim 1, wherein the culture medium in step 4 is prepared by a method comprising: (a) sterilizing a sugar-free soymilk at 121.degree. C. for 15 minutes; (b) diluting the soymilk by water to a protein concentration of 16 mg/mL; and (c) adding 2 wt % glucose to the soymilk according to a diluted volume thereof, sterilizing the soymilk at 121.degree. C. for 5 minutes, and then cooling the soymilk for ready to use. 7. The method of claim 1, wherein the culture medium in step 5 is centrifuged at a speed of 8,000-10,000 rpm for 10-15 minutes. 8. The method of claim 1, wherein the supernatant in step 6 is filtered by a 0.45 .mu.m filter.

Details for Patent 10,064,906

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Zenpep, Llc	ZENPEP	pancrelipase	Capsule, Delayed Release	022210	August 27, 2009		2035-12-31
Zenpep, Llc	ZENPEP	pancrelipase	Capsule, Delayed Release	022210	June 15, 2011		2035-12-31
Zenpep, Llc	ZENPEP	pancrelipase	Capsule, Delayed Release	022210	July 13, 2011		2035-12-31
Zenpep, Llc	ZENPEP	pancrelipase	Capsule, Delayed Release	022210	March 25, 2014		2035-12-31

International Patent Family for US Patent 10,064,906

Country	Patent Number	Estimated Expiration
United States of America	2017189461